[1]
B. F. . Santoro and M. . Casalnuovo, “Presence of PIK3CA mutation in patients with stage IV luminal breast cancer and its relationship with rapid progression”, South Health and Policy, vol. 3, p. 120, Dec. 2024, doi: 10.56294/shp2024120.